355 related articles for article (PubMed ID: 20088735)
1. Omega-3 fatty acids and cognitive function in women.
Robinson JG; Ijioma N; Harris W
Womens Health (Lond); 2010 Jan; 6(1):119-34. PubMed ID: 20088735
[TBL] [Abstract][Full Text] [Related]
2. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).
Ammann EM; Pottala JV; Robinson JG; Espeland MA; Harris WS
Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():68-75. PubMed ID: 28651700
[TBL] [Abstract][Full Text] [Related]
3. Omega-3 fatty acids and risk of cognitive impairment and dementia.
Laurin D; Verreault R; Lindsay J; Dewailly E; Holub BJ
J Alzheimers Dis; 2003 Aug; 5(4):315-22. PubMed ID: 14624027
[TBL] [Abstract][Full Text] [Related]
4. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?
Cederholm T; Palmblad J
Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):150-5. PubMed ID: 20019606
[TBL] [Abstract][Full Text] [Related]
5. ω-3 fatty acids in the prevention of cognitive decline in humans.
Cederholm T; Salem N; Palmblad J
Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
[TBL] [Abstract][Full Text] [Related]
6. A protocol for a randomised controlled trial investigating the effect of increasing Omega-3 index with krill oil supplementation on learning, cognition, behaviour and visual processing in typically developing adolescents.
van der Wurff IS; von Schacky C; Berge K; Kirschner PA; de Groot RH
BMJ Open; 2016 Jul; 6(7):e011790. PubMed ID: 27401364
[TBL] [Abstract][Full Text] [Related]
7. The older people, omega-3, and cognitive health (EPOCH) trial design and methodology: a randomised, double-blind, controlled trial investigating the effect of long-chain omega-3 fatty acids on cognitive ageing and wellbeing in cognitively healthy older adults.
Danthiir V; Burns NR; Nettelbeck T; Wilson C; Wittert G
Nutr J; 2011 Oct; 10():117. PubMed ID: 22011460
[TBL] [Abstract][Full Text] [Related]
8. Dietary omega-3 fatty acids for women.
Bourre JM
Biomed Pharmacother; 2007; 61(2-3):105-12. PubMed ID: 17254747
[TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial investigating the effect of n-3 long-chain polyunsaturated fatty acid supplementation on cognitive and retinal function in cognitively healthy older people: the Older People And n-3 Long-chain polyunsaturated fatty acids (OPAL) study protocol [ISRCTN72331636].
Dangour AD; Clemens F; Elbourne D; Fasey N; Fletcher AE; Hardy P; Holder GE; Huppert FA; Knight R; Letley L; Richards M; Truesdale A; Vickers M; Uauy R
Nutr J; 2006 Aug; 5():20. PubMed ID: 16945130
[TBL] [Abstract][Full Text] [Related]
10. Transfer of omega-3 fatty acids across the blood-brain barrier after dietary supplementation with a docosahexaenoic acid-rich omega-3 fatty acid preparation in patients with Alzheimer's disease: the OmegAD study.
Freund Levi Y; Vedin I; Cederholm T; Basun H; Faxén Irving G; Eriksdotter M; Hjorth E; Schultzberg M; Vessby B; Wahlund LO; Salem N; Palmblad J
J Intern Med; 2014 Apr; 275(4):428-36. PubMed ID: 24410954
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids and cognitive function.
Welty FK
Curr Opin Lipidol; 2023 Feb; 34(1):12-21. PubMed ID: 36637075
[TBL] [Abstract][Full Text] [Related]
12. New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review.
Andriambelo B; Stiffel M; Roke K; Plourde M
Ageing Res Rev; 2023 Mar; 85():101835. PubMed ID: 36603691
[TBL] [Abstract][Full Text] [Related]
13. ω-3 fatty acids and domain-specific cognitive aging: secondary analyses of data from WHISCA.
Ammann EM; Pottala JV; Harris WS; Espeland MA; Wallace R; Denburg NL; Carnahan RM; Robinson JG
Neurology; 2013 Oct; 81(17):1484-91. PubMed ID: 24068783
[TBL] [Abstract][Full Text] [Related]
14. [Contribution of omega-3 fatty acids for memory and cognitive function].
Waitzberg DL; Garla P
Nutr Hosp; 2014 Sep; 30(3):467-77. PubMed ID: 25238820
[TBL] [Abstract][Full Text] [Related]
15. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
Phillips MA; Childs CE; Calder PC; Rogers PJ
Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
[TBL] [Abstract][Full Text] [Related]
16. Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline.
Yurko-Mauro K
Curr Alzheimer Res; 2010 May; 7(3):190-6. PubMed ID: 20088810
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids: new insights into the pharmacology and biology of docosahexaenoic acid, docosapentaenoic acid, and eicosapentaenoic acid.
Davidson MH
Curr Opin Lipidol; 2013 Dec; 24(6):467-74. PubMed ID: 24184945
[TBL] [Abstract][Full Text] [Related]
18. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
Phillips MA; Childs CE; Calder PC; Rogers PJ
Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
[TBL] [Abstract][Full Text] [Related]
19. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial.
Freund-Levi Y; Eriksdotter-Jönhagen M; Cederholm T; Basun H; Faxén-Irving G; Garlind A; Vedin I; Vessby B; Wahlund LO; Palmblad J
Arch Neurol; 2006 Oct; 63(10):1402-8. PubMed ID: 17030655
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine Status Modifies the Treatment Effect of Omega-3 Fatty Acids on Cognition in a Randomized Clinical Trial in Mild to Moderate Alzheimer's Disease: The OmegAD Study.
Jernerén F; Cederholm T; Refsum H; Smith AD; Turner C; Palmblad J; Eriksdotter M; Hjorth E; Faxen-Irving G; Wahlund LO; Schultzberg M; Basun H; Freund-Levi Y
J Alzheimers Dis; 2019; 69(1):189-197. PubMed ID: 30958356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
